Real-time enrollment status for this unresectable hepatocellular carcinoma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 4:01 AM UTC
| NCT Number | NCT05096715 |
| Recruiting Status | Recruiting |
| Condition | Unresectable Hepatocellular Carcinoma |
| Phase | PHASE1 |
| Target Enrollment | 20 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Massachusetts General Hospital |
| Last Updated on CT.gov | February 18, 2026 (Feb 18, 2026) |
As of July 18, 2026: Clinical trial NCT05096715 is currently recruiting participants. This phase1 study for unresectable hepatocellular carcinoma is actively seeking new participants at 3 locations across the United States. The study is sponsored by Massachusetts General Hospital. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05096715 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05096715 was last updated Feb 18, 2026 (February 18, 2026). HelloStudys verifies this status automatically.